CCR2 and breast cancer: We conducted an examination of the CCR2/PPARα/ATGL pathway in adipose tissues adjacent to normal breast tissue (non‐peritumoral AT) and those adjacent to breast cancer tissue (peritumoral AT) from the same patients.